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Abstract
We have designed a four-helix protein that is expected to tetramerize in the membrane to form an ion channel with a
structurally well-defined pore. This should serve as a model system to study the structural requirements of voltage-sensitive,
ion-selective transmembrane channels. We have synthesized the peptide corresponding to the channel-lining helix. Circular
 .dichroism CD spectroscopy shows that this peptide is helical in the membrane. Fluorescence resonance energy transfer
 .FRET shows that this peptide, at low concentrations, forms aggregates in 1,2-dimyristoyl-sn-glycero-3-phosphatidylcho-
 .line DMPC liposomes and facilitates ion transport across liposomal membranes. Our data indicate that a component of the
designed four-helix protein, i.e., the channel-lining helix, behaves as per design. q 1997 Elsevier Science B.V.
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1. Introduction
The three-dimensional structure of a protein is
dictated by the sequence of its constituent amino
acids, but it has not thus far been possible to develop
reliable algorithms leading from a primary sequence
to its three-dimensional structure. One approach to
this problem has been to design proteins based on the
propensity of certain amino acid residues to adopt
Abbreviations: ALH, resin with acid labile handle; AcPCH3,
acetylated PCH3; CD, circular dichroism; CTC, chlortetracycline;
Dans, dimethylaminonaphthylsulfonamide; DMPC, 1,2-di-
myristoyl-sn-glycero-3-phosphatidylcholine; FRET, fluorescence
resonance energy transfer; PCH3, peptide corresponding to helix
no. 3; PCH3-Dans, dansyl derivative of PCH3; UV, ultraviolet;
X537A, laslocid
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preferred conformations. Four helix bundles such as
w xFELIX have been so designed 1 . Other attempts on
w xthe same lines have been less successful 2 . Indeed, a
common failing of synthetic proteins appears to be
that while they may adopt secondary structures as
predicted, their tertiary structures are very poorly
w xdefined 3 . Introducing constraints such as metal
w xbinding sites has led to better defined structures 4 .
More recently, it has been possible to design proteins
without such constraints that do adopt the desired
w xstructures 5,6 . Membrane proteins are constrained to
adopt a limited range of secondary structures. Once a
polypeptide chain enters the membrane phase, polar
groups on its backbone are no longer able to hydro-
gen bond with solvent and consequently are forced
into hydrogen bond interactions with other backbone
polar groups. Shielding would be maximized by ei-
ther helical or b-structures. Structural data on the few
0005-2736r97r$17.00 q 1997 Elsevier Science B.V. All rights reserved.
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membrane proteins studied to date are consistent with
w xsuch an analysis 7–9 . The determinants of tertiary
structure in such cases are, however, unclear.
The Shaker Kq-channels represent a family of
wvoltage-gated potassium-selective ion channels 10–
x12 . The functional channel has four subunits, each
w xhaving six putative transmembrane segments 12
with contributions to the pore liner coming from all
w xfour subunits 13,14 . Formation of a stable pore with
a well-defined conductance in such a protein requires
that tertiary interactions stabilize the pore. While the
structural basis of the selectivity filter in these pro-
teins is not well understood, it is likely that it would
require the side chains of the constituent residues to
adopt a very precise three-dimensional arrangement.
Thus, designing a protein that will tetramerize in the
membrane and form channels with a well-defined
conductance requires designing a protein with a
well-defined tertiary structure.
We have designed a protein, SYNCHAN, that
should tetramerize in membranes to form a non-selec-
 .tive, ungated pore Seth et al., in preparation . The
channel liner for this protein is an amphipathic helix,
the polar face of which is based loosely on the
alamethicin–zervamicin family of fungal peptide an-
w xtibiotics 15 . The other faces have been designed
based on bacteriorhodopsin helices known to associ-
w xate strongly with each other 16 . In this communica-
tion, we report on the ability of a peptide correspond-
ing to this de novo designed channel liner to mediate
ion transport through liposomal membranes and char-
acterize the structural basis for channel formation by
this peptide.
2. Materials and methods
2.1. Materials
A polyamide resin with an acid labile handle
 . ALH was purchased from Ultrosyn Ultrosyn
.  .ResinA , LKB Biochrom Ltd. Cambridge, UK . All
Fmoc-Amino acids, OPfp esters except for Ser and
.Thr, DHBT esters for Ser and Thr , hydroxybenztria-
 .  .zole HOBT , dimethylaminopyridine DMAP were
 .from Novasyn-Novabiochem Nottingham, UK .
Amino acids, 1-dimethylamino-naphthalene-5-
 .  .sulfonic acid dansic acid , chlortetracycline CTC ,
 .laslocid X537A and dimyristoylphosphatidylcholine
 .DMPC were from Sigma. Tertiary amyl alcohol
 .was from Ultrosyn, trifluoroacetic acid TFA from
 .Sigma and dicyclohexylcarbodiimide DCC ,
 .ethanedithiol EDT , anisole were from Merck, India.
 .Dimethylformamide DMF , dichloromethane
 .DCM , acetonitrile, methanol, acetone were from
Ranbaxy, India, and diethylether from Qualigens,
India. All solvents were distilled prior to use. Soya-
lecithin was obtained from a local source, and recrys-
talized from acetone.
2.2. Peptide synthesis and acetylation
The peptide was synthesized on a flow synthesizer
 .LKB Biochem-Biolynx 4175 on a scale of 1 g of
 .Ultrosyn ResinA 0.1 mmol using Fmoc chemistry
w x17 . The first residue was attached using Fmoc-Trp-
OPfp ester. A part of the peptide was acetylated at its
w xN-terminus, using acetic anhydride 17 before cleav-
age from the resin.
2.3. Dansylation of the peptide
Another part of the peptide was dansylated at its
N-terminus, using dansyl chloride. Recrystalized dan-
syl-chloride was prepared following the procedure
w xdescribed 18 . In brief, 1 g of dansic acid was taken
 .in 3 ml of phosphorous-oxychloride POCl and 1.63
 .g of phosphorous pentachloride PCl added slowly5
until the mixture turned homogeneous. The resulting
mixture was poured into ;80 g of ice; extracted
with benzene, washed with dilute alkali, dried over
calcium chloride and the benzene evaporated off. The
resulting reddish-orange oil solidified on storing at
y208C. Finally it was recrystalized from light
petroleum ether. The peptide was dansylated at its
free N-terminus on the resin prior to cleavage and
deprotection as follows. One hundred milligrams of
resin was taken in 3 ml of dry methanol. Ten mil-
ligrams of freshly prepared dansylchloride and 5 ml
 .of triethylamine TEA were added and the mixture
incubated at room temperature overnight. Excess dan-
sylchloride was washed off with methanol followed
by diethylether. Cleavage and deprotection were car-
ried out by standard methods.
The peptide and its derivatives were checked for
 .purity by analytical HPLC Shimadzu SPD6a on a
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C reversed phase column. Two dimensional NMR18
 .studies 400 mHz of the undansylated peptides con-
firmed their composition and sequence. The
peptiderderivatives synthesized were:
 .PCH3, YC Acm FALQFAPSLITFTVFLLTLW;
PCH3-Dans, PCH3 dansylated at the N-terminus;
AcPCH3, PCH3 acetylated at the N-terminus.
2.4. Fluorescence spectroscopy
Fluorescence spectra were recorded on a SPEX
Fluorolog 2 with 1.8 nm excitation bandpass and 1.25
nm emission bandpass with a step size of 0.5 nm per
point and an integration time of 1.0 s. Four scans
were averaged for each spectrum. Energy transfer
efficiencies were estimated from emission spectra
recorded from equal amounts of dansylated and un-
dansylated peptide excited at 285 nm. The decrease
of emission intensity at the tryptophan peak is related
to the efficiency of energy transfer.
EsTransfer efficiencys 1yF rF 1A .  .DA D
where F and F are the emission intensities ofD DA
tryptophan in absence and presence of the acceptor,
respectively. Assuming free rotation of both the donor
and the acceptor, the distance between the two is
given by
1r6y1RsR E y1 1B .  .0
where R is the distance at which the efficiency is0
˚w x50% 19 . R is reported to be 23.0 A for the0
w xtryptophan–dansyl pair 20 .
2.5. CD spectroscopy
CD spectra were recorded on a Jasco 720A
spectropolarimeter after the instrument was calibrated
 .with q -10-camphorsulfonic acid. A 1-cm path-
length cell was used and spectra scanned at 50
nmrmin in steps of 0.025 nm. Sixty-four scans were
averaged for each spectrum. Peptide concentrations
were in the range of 1–3 mM. The mean residue
elipticity was estimated as:
u sur 10=Concentration in molarity
=pathlength in cm=no. of residues 2.  .
2.6. Preparation of small unilamellar ˝esicles
 .Small unilamellar vesicles SUV were prepared
w xfollowing the procedure described in 21 except that
soya-lecithin or DMPC was used. Briefly, dry lipid
was dissolved in a chloroformrmethanol mixture
 .3:1, vrv . The solvents were evaporated under a
stream of nitrogen until a thin film was deposited on
the walls of the test tube. The thin film thus obtained
was then resuspended in 5 mM HEPES buffer pH
.7.0 containing 100 mM NaCl. The resulting lipid
dispersion was then sonicated using a microtip probe
 .Virsonic 475 until optical clarity was achieved. The
clear suspension was centrifuged at 100 000=g for 1
h at 48C and the upper 2r3 of the supernatant used
for subsequent measurements. The final concentration
of lipid was 15 mgrml.
2.7. Ion-transport measurements
Ion transport was assayed fluorimetrically on a
w xSPEX Fluorolog 2 as described in 22 . Briefly, 100
ml of the liposome suspension was taken in a 3 ml
fluorescence cuvette along with 10 ml of 2.3 mM
CTC solution in de-ionized water. After incubation
for 2–3 min, the mixture was diluted with 1.8 ml of
buffer and stirred continuously while monitoring at
l s400 nm and l s530 nm. Fifty microliters ofex em
40 mM CaCl solution was added after collecting a2
baseline. Test samples were delivered through an
injection port as a methanolic or aqueous solution
after a steady state had been achieved. An influx of
calcium into the liposomes mediated by the injected
sample can be detected as an increase in the intensity
of CTC fluorescence.
3. Results and discussion
3.1. Design of SYNCHAN
We have designed a four-helix protein that should
tetramerize in the membrane to form ion-conducting
pores. The protein, SYNCHAN, should thus serve as
a model for Shaker-type potassium channels which
are also tetrameric. Fig. 1A shows a schematic
cross-section of the functional channel. The design
requires that helix 4 associates with helix 2, helix 3,
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Fig. 1. A: the synthetic channel is designed to be a tetramer of a
 .protein with 4 transmembrane helices, one of which no. 3 here
lines the channel. The cross section of the assembled tetramer is
shown, with the channel liner hatched. The central pore is also
indicated in this panel. B: helical-wheel representation of the
peptide PCH3, viewed down the helix axis. The arc from Cys2 to
Ser10 with residues in boldface is designed to line the aqueous
pore.
and lipid; while helix 3 should associate with helix 2
and helix 4 and also line the channel. Faces of helices
that interact extensively in the bacteriorhodopsin
w xstructure 8 have been used in the design. The inter-
acting faces from helices A and B in the bacterio-
rhodopsin structure have been transposed onto the
helix 1–helix 4 pair in SYNCHAN. Other interacting
faces of SYNCHAN were designed in an analogous
manner using other interacting pairs of helices of
bacteriorhodopsin. Faces of helices that are exposed
to lipid have been made up of predominantly hy-
drophobic residues, while the channel-lining face of
helix 3 has been loosely modeled on the
alamethicin–zervamicin family. It should be empha-
sized that while individual faces of helices have been
based on the structure of bacteriorhodopsin, an opti-
mal alignment of SYNCHAN and bacteriorhodopsin
sequences yields only 25 matches out of 130 SYN-
CHAN residues. It is thus a protein with very limited
homology to any known sequence.
The channel-lining helix, helix 3, interacts with
helices 2 and 4 of the same subunit, helix 3’s of the
neighboring subunits and the aqueous pore. It has
been designed as an amphipathic helix with five out
of the six residues lining the pore being polar Fig.
.  .1B . The peptide corresponding to helix 3 PCH3
was synthesized by solid phase peptide synthesis. In
analogy to the alamethicin–zervamicin family, the
peptide is expected to insert into the membrane and
form helical aggregates therein which enclose an
w xaqueous pore that can mediate ion transport 23 .
3.2. CD and fluorescence studies of structure
The CD spectrum of AcPCH3 in the presence of
 .DMPC liposomes Fig. 2 shows two negative bands
characteristic of a-helical conformation. Since the
CD spectra of small peptides containing aromatic
residues reflect the algebraic sum of contributions
from the peptide bonds and from the aromatic
residues, estimates of fractional helicity from such
w xspectra should be viewed with caution 24,25 . For
the same reason, we have not used any curve decon-
volution programs to estimate fractional helicity in
Fig. 2. Far-UV CD spectra of AcPCH3, 1.25 mM, in liposomes at
258C. The lipid concentration is 0.75 mgrml.
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this peptide. We have investigated the structure of the
peptide in methanol–water systems and in liposomes
and shown that it is a-helical in methanol and lipo-
w xsomes, but adopts b-structures in aqueous buffer 26 .
The observed CD spectrum of the peptide in liposo-
mal suspensions appears a-helical, implying that the
w xpeptide has inserted into the membrane 26 .
PCH3 is intrinsically fluorescent with a tyrosine at
its N-terminus and a tryptophan at its C-terminus. We
have also prepared a dansylated derivative with the
 .dansyl group attached to its N-terminus PCH3-Dans .
The emission spectrum of the dansyl group is very
sensitive to its environment, the emission maximum
shifting from around 560 nm in aqueous solution to
w xshorter wavelengths in apolar media 22 . The emis-
sion spectrum of tryptophan is also sensitive to sol-
vent polarity, but the wavelength range is much more
restricted. Fig. 3 presents emission spectra of PCH3
and PCH3-Dans in HEPES buffer and in liposomes.
On direct excitation of the dansyl group, the emission
maximum of PCH3-Dans shifts from 500 nm in
 .HEPES buffer to 490 nm in liposomes Fig. 3A .
This would indicate that the peptide forms aggregates
in water that effectively shield the chromophore from
solvent. Insertion into the bilayer results in the chro-
mophore sensing an even less polar environment
within the membrane phase. Aqueous phase aggre-
gates of the peptide would be expected to sequester
the apolar faces, thus shielding them from the solvent
while membrane phase aggregates, if formed, would
expose the apolar faces to lipid. The position of the
emission peak of the Dans was essentially invariant
over the concentration range from 0.7 to 5.25 mM,
indicating that it is aggregated throughout this range.
Excitation of tryptophan at 285 nm leads to either
emission from tryptophan or resonance transfer of
energy to the dansyl group and subsequent emission
from that chromophore. The efficiency of this phe-
nomenon falls off with the sixth power of distance
˚and is 50% efficient at a distance of 23.0 A for the
w x  .Trp–Dans pair 20 . In aqueous solution Fig. 3B ,
the presence of the dansyl group decreases the emis-
sion intensity of tryptophan by 34% for a peptide
concentration of 0.7 mM with a concomitant increase
in emission at the dansyl wavelengths. The distance
corresponding to this efficiency of energy transfer is
˚ ˚25.7 A which is less than the 33 A predicted for a
22-residue a-helical peptide. This is unlikely to arise
Fig. 3. A. Fluorescence emission spectra of PCH3-Dans, 1.25
 .  .  .mM in a HEPES buffer pH 7.0 at 258C, and b liposomes at
 .358C lipid concentration 0.75 mgrml . Excitation wavelength is
350 nm. B. Fluorescence emission spectra of AcPCH3, 0.7 mM
 .  . a and PCH3-Dans, 0.7 mM b in liposomes at 358C lipid
.  .concentration 0.75 mgrml ; AcPCH3, 0.7 mM c and PCH3-
 .  .Dans, 0.7 mM d in HEPES buffer pH 7.0 at 258C.
from a population of monomeric peptides with an
˚average end-to-end distance of 25.7 A as the dansyl
emission clearly indicates that the peptide is aggre-
gated. Conversely, interchromophore distances are
˚likely to be much shorter than 20 A in helical,
antiparallel aggregates. Centrifugation at 100 000=g
for 1 h did not affect the spectra recorded, indicating
that the aggregates formed are small.
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The energy transfer efficiency in liposomes is
 .much higher 75% indicative of an average inter-
˚chromophore spacing of 19 A which is significantly
less than the bilayer thickness. Aqueous phase aggre-
gation of the peptide at this concentration resulted in
only 34% energy transfer indicating either that some
of the peptide is monomeric under these conditions or
that the structures of the aggregates in water and in
membranes are very different. The peptide is helical
 .in the membrane Fig. 2 , making intramolecular
transfer unlikely. We, therefore, interpret this data as
indicative of antiparallel aggregation in the mem-
brane. For peptide at a concentration of 0.7 mM
dispersed in 0.75 mgrml lipid with an average head
˚ w xgroup diameter of 10 A 27 , the average spacing
between peptide molecules would be expected to be
˚;105 A, if peptide molecules were randomly dis-
tributed in lipid bilayer. No energy transfer is ex-
˚pected at distances greater than 45 A for the Trp–Dans
pair.
3.3. Ion-transport acti˝ity
The ability to facilitate the transport of calcium
across liposomal membranes is assayed using the
 .calcium indicator dye chlortetracycline CTC en-
trapped within liposomes with calcium present in the
extravesicular buffer. An increase of fluorescence
intensity on adding peptide or a known ionophore is
indicative of an influx of calcium. The integrity of
the vesicles is checked with the calcium ionophore
 .X537A Fig. 4A . The rise in fluorescence intensity
of CTC observed on adding the ionophore requires
that CTC and Ca2q are in separate compartments.
Fig. 4B shows that PCH3 is unable to facilitate ion
transport at a concentration of 3.75 mM when added
from a methanolic solution. Addition of the same
concentration of AcPCH3 from a methanolic solution
results in a rise in CTC fluorescence indicative of ion
transport. On the other hand, addition of 5.25 mM
AcPCH3 from an aqueous solution is ineffective.
However, PCH3-Dans facilitates ion transport at much
 .lower concentrations than AcPCH3 data not shown .
The efficacy of methanolic solutions of PCH3 deriva-
tives parallels their hydrophobicity with PCH3-Dans
being more hydrophobic than AcPCH3 which, in
turn, is more hydrophobic than PCH3 free base.
Fig. 4. A: ion transport across liposomal membranes: CaCl is2
added at the point indicated by arrow 1; arrow 2 indicates the
addition of the ionophore, X537A. B: ion-transport activity of:
 .  .  . a methanolic AcPCH3 3.5 mM ; b aqueous AcPCH3 5.25
.  .  .mM ; and c methanolic PCH3 3.75 mM . The peptide is added
at the point indicated by the arrow. The lipid concentration is
0.75 mgrml.
Addition of AcPCH3 to liposomal suspensions
from methanolic stock results in largely helical pep-
tide inserted into the membrane, whereas addition
w xfrom aqueous stock leads to disordered peptide 26 .
An amount of 1.25 mM AcPCH3 added from
methanolic stock mediates ion-transport activity,
whereas even 5 mM peptide from aqueous stock is
( )S. Seth et al.rBiochimica et Biophysica Acta 1328 1997 177–184 183
 .inactive Fig. 4B . The lack of activity of the aqueous
stock argues against detergent action leading to per-
meabilization. Conversely, the correlation between
the presence of helical peptide in the membrane and
ion-transport activity is consistent with the designed
role of the peptide forming helical aggregates enclos-
ing aqueous pore.
Channel-forming activity in alamethicin fragments
increases with chain length and overall hydrophobic-
ity, the minimum concentration at which activity is
detected scaling with the critical ‘micellar’ concentra-
 . w xtion cmc for dansylated derivatives 28 . These data
were interpreted to indicate that alamethicin inserts
into membranes as preformed aggregates which rear-
w xrange in the membrane to form channels 23,28 . In
the case of PCH3, the free base is inactive, the acetyl
derivative is active at concentrations down to 1.05
mM while the dansyl derivative is active down to 0.3
 .mM data not shown . Hence, it seems reasonable to
conclude that our data with PCH3 and its derivatives
are consistent with such a model for channel forma-
tion.
The ion-transport activity of AcPCH3 increases
with concentration. Fig. 5A shows traces for the
assay run at a range of concentrations from 0.7 to
5.25 mM. The initial slopes of these curves is a good
w xindicator of ionophore activity 29 and this parame-
ter is plotted against concentration in Fig. 5B.
Ionophore activity can be seen down to at least 1.05
mM. The initial slope of fluorescence increase caused
by the authentic ionophore, laslocid, at a concentra-
tion of 20 mM is comparable to that seen with 4.9
mM AcPCH3.
We have not estimated the sizes of the liposomes
used in our assay. However, SUVs prepared by soni-
cation have been reported to range in size from 100
˚ w xto 500 A in diameter 30 . An amount of 1.25 mM
peptide is clearly effective in mediating ion transport
in liposomes at 0.75 mgrml: a ratio of 1 peptide per
˚liposome, assuming a mean liposome size of 300 A.
Increasing the peptide concentration increases the
probability of channel formation in a given liposome
which is reflected in enhanced initial rates of fluores-
cence increase and greater limiting amplitude of the
response. Given that at least 4 monomers would be
required in a liposome to form a channel, these data
are consistent with a channel mechanism for perme-
abilization.
Fig. 5. A: ion-transport activity of AcPCH3 across liposomal
membrane. The peptide is added at the point indicated by the
arrow. Concentrations used are indicated against the traces. The
lipid concentration is 0.75 mgrml. B: the initial slope of the rise
in fluorescence following peptide addition is plotted against the
final concentration of the peptide added.
In summary, the peptide PCH3 which corresponds
to helix 3 of the design for SYNCHAN forms helical
aggregates in liposomal membranes that mediate
transmembrane ion transport. Ease of aqueous phase
aggregation parallels the ability to form channels,
consistent with the requirement for insertion of pre-
formed aggregates into the membrane to form chan-
nels. These properties of the peptide match those
predicted by the design, encouraging further develop-
ment of the SYNCHAN protein.
( )S. Seth et al.rBiochimica et Biophysica Acta 1328 1997 177–184184
Acknowledgements
We thank R. Gurunath, S. Agarwala, A. Banerjee,
R. Gokhale, S. Bhattacharya and M.S. Prachand for
helpful suggestions and C. Ramakrishnan for provid-
ing us with various programs for calculation of inter-
atomic distances. NMR spectra were recorded at the
Sophisticated Instruments Facility, Indian Institute of
Science.
References
w x1 M.H. Hecht, J.S. Richardson, D.C. Richardson, R.C. Ogden,
 .Science 249 1990 884–891.
w x2 B. Lovejoy, S. Choe, D. Cascio, D.K. McRorie, W.F.
 .DeGrado, D. Eisenberg, Science 259 1993 1288–1293.
w x3 S.F. Betz, D.P. Raleigh, W.F. DeGrado, Curr. Opin. Struct.
 .Biol. 3 1993 601–610.
w x4 T.M. Handel, S.A. Williams, W.F. DeGrado, Science, in
press.
w x5 T.P. Quinn, N.B. Tweedy, R.W. Williams, J.S. Richardson,
 .D.C. Richardson, Proc. Natl. Acad. Sci. USA 91 1994
8747–8751.
w x6 M.D. Struthers, R.P. Cheng, B. Imperiali, Science 271
 .1996 342–345.
w x  .7 J. Deisenhofer, H. Michel, Science 245 1989 1463.
w x8 R. Henderson, J.M. Baldwin, T.A. Ceska, F. Zemlin, E.
 .Beckmann, K.H. Downing, J. Mol. Biol. 213 1990 899–
929.
w x  .9 A. Kreusch, G.E. Schulz, J. Mol. Biol. 243 1994 891–905.
w x10 A. Baumann, I. Krah-Jentgens, R. Mueller, F. Mueller-
Holtkamp, R. Seidel, N. Kecksemethy, J. Casal, A. Ferrus,
 .O. Pongs, EMBO J. 6 1987 3419–3429.
w x  .11 A. Kamb, L.E. Iverson, M.A. Tanouye, Cell 50 1987
405–413.
w x12 B.L. Tempel, D.M. Papazian, T.L. Schwarz, Y.N. Jan, L.Y.
 .Jan, Science 237 1987 770–775.
w x  .13 L. Heginbotham, R. MacKinnon, Neuron 8 1992 483–491.
w x  .14 R. Mackinnon, Nature 350 1991 232–235.
w x15 I.L. Karle, J.L. Flippen-Anderson, S. Agarwalla, P. Balaram,
 .Proc. Natl. Acad. Sci. USA 88 1991 5307–5311.
w x16 K.S. Huang, M.J. Liao, C.M. Gupta, N. Royal, K. Biemann,
 .H.G. Khorana, J. Biol. Chem. 257 1982 8596–8599.
w x17 E. Atherton, R.C. Sheppard, Solid Phase Peptide Synthesis:
A Practical Approach, IRL Press, Oxford, 1989.
w x  .18 R. Mendel, J. Chem. Eng. Data 15 1970 340–343.
w x19 J.R. Lakowicz, Topics in Fluorescence Spectroscopy: Princi-
ples, Vol. 2, Plenum Press, New York, 1992.
w x  .20 R.H. Conrad, L. Brand, Biochemistry 7 1968 777–787.
w x21 Y. Barenholz, D. Gibbes, B.J. Litman, J. Goll, T.E. Thomp-
 .son, F.D. Carlson, Biochemistry 16 1977 2806–2810.
w x22 R. Nagaraj, M.K. Mathew, P. Balaram, FEBS Lett. 121
 .1980 365–368.
w x  .23 M.K. Mathew, P. Balaram, Mol. Cell. Biochem. 50 1983
47–64.
w x24 A. Chakrabartty, T. Kortemme, S. Padmanabhan, R.L. Bald-
 .win, Biochemistry 32 1993 5560–5565.
w x25 S. Vuilleumier, J. Sancho, R. Loewenthal, A.R. Fersht,
 .Biochemistry 32 1993 10303–10313.
w x26 S. Seth, P. Balaram, M.K. Mathew, Current Sci., in press.
w x27 L. Stryer, Biochemistry, 3 ed., W.H. Freeman and Com-
pany, New York, 1988.
w x28 M.K. Mathew, R. Nagaraj, P. Balaram, J. Biol. Chem. 257
 .1982 2170–2176.
w x29 M.K. Mathew, R. Nagaraj, P. Balaram, J. Membr. Biol. 65
 .1982 13–17.
w x30 R.R.C. New, Liposome: A practical Approach, Oxford Uni-
versity Press, New York, 1990.
